Global Health Economic Evidence Assessment
Planning: Determination which health economic assessments are essential for your product from the market launch, the HTA/payer and the KOL/provider perspective.
Generation: Development and application of health economic evaluations and/or models in order to generate the health economic evidence for your product.
Dissemination: Communication of the health economic value messages (based on the health economic assessment results) to decision makers, payers, providers & KOLs.
Market Access and Reimbursement in Germany
Market Access & Reimbursement: Evaluation and implementation of market access strategies and of reimbursement strategies for digital health applications, medical devices and for pharmaceuticals in Germany.
To learn more about health economic services please refer to the AHEAD - Capability Presentation including Health Economic Project Showcases.
Medical Devices & DiGAs
To learn more about market access and reimbursement of medical devices and DiGAs in Germany please refer to the specific Medical Device and Digital Health Application Presentation.
To learn more about market access and reimbursement of pharmaceuticals in Germany please refer to the specific Pharmaceutical Presentation.